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Abstract
Objective—The association of obesity susceptibility variants with change in body mass index 
(BMI) across the life course is not well understood.
Subjects—In ancestry stratified models of 5,962 European American (EA), 2,080 African 
American (AA), and 1,582 Hispanic American (HA) individuals from the National Longitudinal 
Study of Adolescent to Adult Health (Add Health), we examined associations between 34 obesity 
SNPs with per year change in BMI, measured by the slope from a growth-curve analysis of two or 
more BMI measurements between adolescence and young adulthood. For SNPs nominally 
associated with BMI change (p<0.05), we interrogated age differences within data collection Wave 
and time differences between age categories that overlapped between Waves.
Results—We found SNPs in/near FTO, MC4R, MTCH2, TFAP2B, SEC16B, and TMEM18 
were significantly associated (p<0.0015 ≈ 0.05/34) with BMI change in EA and the ancestry-
combined meta-analysis. Rs9939609 in FTO met genome-wide significance at p<5e-08 in the EA 
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and ancestry combined analysis, respectively [Beta(se)=0.025(0.004);Beta(se)=0.021(0.003)]. No 
SNPs were significant after Bonferroni correction in AA or HA, although 5 SNPs in AA and 4 
SNPs in HA were nominally significant (p<0.05). In EA and the ancestry-combined meta-analysis, 
rs3817334 near MTCH2 showed larger effects in younger respondents, while rs987237 near 
TFAP2B, showed larger effects in older respondents across all Waves. Differences in effect 
estimates across time for MTCH2 and TFAP2B are suggestive of either era or cohort effects.
Conclusion—The observed association between variants in/near FTO, MC4R, MTCH2, 
TFAP2B, SEC16B, and TMEM18 with change in BMI from adolescence to young adulthood 
suggest that the genetic effect of BMI loci varies over time in a complex manner, highlighting the 
importance of investigating loci influencing obesity risk across the life course.
Keywords
Gene-environment interactions; adolescence; obesity; BMI change; African-American; Hispanic-
American
INTRODUCTION
The transition from adolescence to young adulthood is a period of high risk for weight gain 
and development of obesity [1–3], with high rates of incident obesity (24.1%) and severe 
obesity (7.9%) [3]. Genome-wide association (GWAS) studies of over 200,000 European 
descent adults, have identified several independent loci associated with BMI [4, 5]. While 
recent studies have analyzed BMI loci across the lifecycle [6–14], few longitudinal studies 
have examined BMI loci associated with change in body mass index (BMI) in the period 
between adolescence and young adulthood. Several studies have examined the association of 
FTO and MC4R, two of the earliest identified BMI susceptibility variants, with longitudinal 
change in BMI from childhood into adulthood [6–8, 15]. Results for BMI change with FTO 
and MC4R suggest stronger estimated effects encompassing the early adolescent to young 
adult period compared to later in adulthood [6, 7, 15]. Further, childhood growth trajectories 
from age one to 16 years have been shown to be associated with established BMI 
susceptibility loci as a risk score [13], suggesting that genetic determinants associated with 
BMI at cross-sectional periods are also associated with changes in BMI across the life 
course. Studies of the influence of genetic variants on BMI change have not yet been 
interrogated during the late adolescent to early adulthood transition, a developmental period 
associated with substantial BMI change. More research is warranted to determine the impact 
of BMI genetic variants across this phase of the life course.
In this study, we examined the association between 34 established BMI variants and change 
in BMI derived from measured height and weight assessed from adolescence to early 
adulthood in youth enrolled in an ethnically diverse, nationally representative cohort, the 
National Longitudinal Study of Adolescent to Adult Health (Add Health), followed for 13 
years across three time points, which we call Waves, between 1996 and 2008 when the 
cohort fell between the ages of 13 years and 34 years. We hypothesized that carriers of 
obesity risk alleles would have a greater rate of change in increasing BMI across the 
adolescent and early-adulthood time period. In addition, because of increasing 
environmental influences that might mask genetic ones as we age, we speculated that some 
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variants might have comparatively stronger estimated effects at earlier versus later ages of 
the period between adolescence and young adulthood.
METHODS
Add Health
Participants—Add Health is a nationally representative school-based cohort of US 
adolescents (Wave I: 1994–95, n=20,745, aged 11–20 y, mean age 15.9 y) drawn from a 
probability sample of 80 high schools and 52 middle schools, representative of US schools 
in 1994–95 with respect to region, urban setting, school size and type, and race or ethnic 
background. Wave II (1996, n = 14,738, aged 12–21 y, mean age 16.5 y) included by design 
Wave I adolescents still of school age, including those currently in high school and high 
school dropouts. Oversampled subgroups include related and non-related adolescents 
sharing a Wave I household (n=5,524 Wave I respondents living in 2,639 households) [16] 
and several race/ethnic subpopulations, including Chinese, Cubans, Puerto Ricans, and 
Filipinos. Wave III (2001–2002, n= 15,197, aged 18–27 y, mean age 22.3 y) and Wave IV 
(2008–2009, n=15,701, aged 23–32 y, mean age 28.9 y) followed all Wave I respondents, 
regardless of Wave II participation. The most recent data collection (Wave IV) included 
follow-up interviews from 15,701 respondents drawn from 19,962 of the original 20,745 
Wave I respondents and included DNA collection and banking for future studies. Survey 
procedures have been described elsewhere [17–19], and were approved by the Institutional 
Review Board, University of North Carolina at Chapel Hill.
Literature-based SNPs and Genotyping—We selected 34 SNPs associated with BMI 
reported by the Genetic Investigation of ANthropometric Traits (GIANT) consortium 
(Supplementary Table 1) and other studies in European adults [4, 20–24]. Familial 
relationships were classified according to participant and parental self-report. Twin zygosity 
was confirmed by 11 molecular genetic markers [25]. Genotyping was performed using 
TaqMan assays and the ABI Prism 7900® Sequence Detection System (Applied Biosystems, 
Foster City, CA, USA). Sequences for primers and TaqMan probes are available upon 
request. Procedures for genotyping (call rate 98%, discordance 0.3%) have been detailed 
elsewhere [26].
Ancestry—Ancestry was constructed using race and ethnic background and family 
relationship status (i.e. country of origin, ancestry, and adoption): European American (EA), 
African American (AA), and Hispanic American (HA), with indicators for subpopulation 
(e.g., Mexican, Cuban) and immigrant status (e.g., US and non-US born), given differences 
in BMI by immigrant status [27, 28].
Analysis sample
We included individuals with phenotype data in at least two Waves of data collection, and 
those that had at least 80% of the SNPs genotyped (n=10,710). In addition, we excluded one 
from each twin pair (n=142 pairs) with the fewest genotypes SNPs, Asian, Native American 
or other race/ethnicity (n=719); disabled (n=76); and individuals missing covariate data 
(n=125) or pregnant at all BMI observations available (n=18). BMI was set to missing for 
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women who were pregnant at a particular observation. The final analytic sample included 
9,624 individuals measured at Waves II, III, and/or IV with DNA data (Supplementary 
Figure 1). Wave I included only self-reported height and weight and was only one year prior 
to Wave II, thus we did not include these self-reported observations. Within each of three 
ethnic groups, sample sizes were comprised of 5,962 EA, 2,080 AA, and 1,582 HA. When 
analyzing AAs, we excluded 12 of 34 SNPs (rs2568958, rs1514175, rs1555543, rs887912, 
rs2890652, rs13078807, rs2112347, rs4929949, rs4771122, rs11847697, rs571312, rs29941; 
see notes in all tables) that did not show evidence of association at p<0.20 and consistent 
direction of effect in AA GWAS [29, 30]. Given the lack of large GWAS in Hispanics, and 
the observation that 75% of GWAS SNPs for complex traits were replicated in Hispanics 
[31], all 34 SNPs were considered in analyses of this population.
Statistical analysis
Outcome Measure: Change in Body Mass Index (BMI)—BMI (kg/m2) was 
calculated from measured height and weight taken at Waves II, III and IV during in-home 
surveys using standardized procedures. Self-reported height and weight (r=0.95/0.94 with 
measured weight/height [32]) were substituted for those refusing measurement and/or 
weighing more than scale (Health-o-meter 844KL digital scale, Jarden Corporation; Rye, 
NY) capacity (n=163 at Wave II, n=371 at Wave III, and n=82 at Wave IV). The maximum 
scale at all waves was 200 kg / 440 lbs maximum. We used BMI rather than Z-scores as is 
common in the literature [33–35], which allows more straightforward interpretation. 
Individual participant linear slopes were derived using the best linear unbiased prediction 
method (“BLUP”), regressing BMI on age as both a fixed and random effect. We also 
adjusted for current smoking at the indicated Wave, and an indicator for whether or not 
height and weight was self-reported as fixed effects. Models were run by sex to account for 
sex-specific differences in weight across time and by ancestry to account for ancestry 
differences in weight gain over time. Of the 9,624 individuals in the analyses, 6,403 had 3 
BMI measurements used to create the slope and 3,221 had 2 BMI measurements (1,296 with 
BMI at Wave II and Wave IV, 1,913 with BMI at Wave III and Wave IV, and 12 with BMI at 
Wave II and Wave III) to create their slope.
Association analyses—Ancestry-stratified association analyses between change in BMI 
and SNP genotype were conducted using linear mixed models incorporated in Stata, version 
12.1 (Stata Corp, College Station, TX. Each SNP was modeled under an additive model, 
with SNPs scored for the number of copies of the established (from prior GWAS) risk allele 
or ‘BMI-increasing’ allele. Covariates included baseline age, sex, geographic region, 
oversampling of highly educated AAs (n=520), Hispanic ancestry: Cuban (n=284), Puerto 
Rican (n=275), Central/South American (n=160), Mexican (n=863), other Hispanic (n=102), 
and if the participant was foreign born (n=432). Study design effects and relatedness were 
accounted for using random effects for school and family (of the 9,624 total individuals, 
1744 (18%) were related or shared a household with another individual in the sample). 
Effect estimates were combined and meta-analyzed in METAL using the inverse standard-
error weighted approach [36]. For each SNP association, we evaluated heterogeneity 
between race/ethnic groups using Cochran’s Q. We considered evidence for heterogeneity 
when the chi-square p <0.10 or I2 index >50[37, 38]. While we examined all nominally 
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significant findings (p<0.05), we corrected for multiple testing: α = 0.05/number of SNPs 
tested (p≤0.0015 in EA, p≤0.0015 in HA, and p≤0.0023 in AA, and p≤0.0015 in the 
combined meta-analyzed sample). We also ran models without including any SNPs 
(Supplementary Table 2).
For SNPs with nominally significant effects (p<0.05) on the change in BMI, we interrogated 
two additional sets of analyses to assess whether the effects on change in BMI were due to 
different effects across age groups or points in time, the latter for which we use Wave of data 
collection. Given the narrow age range among participants (approximately 10 year age-span) 
within each Wave of data collection, cohort and age effects are highly collinear. Thus, to 
interrogate whether SNP effects vary by age, we performed SNP-by-age interaction analyses 
on cross-sectional BMI at each Wave. This set of analyses considered that a locus might 
have a stronger effect in younger compared to older individuals within the full age range 
studied (e.g., 12–21 years at Wave II) or vice versa. To keep the sample size constant when 
testing for the SNP-by-age interaction at each Wave, we included a subsample of 
participants with measured anthropometry at Waves II, III and IV. This reduced our sample 
size to 6,190 (3,155 females and 3,035 males). To aid in interpretation of the SNP-by-age 
interaction results, we plotted the results by year of age at each Wave, except for ages 13–14 
and ages 18–21, which we combined due to smaller sample sizes. Second, we examined the 
main genetic effects of each SNP on cross-sectional BMI between individuals at similar ages 
but at a different Wave of data collection Wave, to verify that the main effect of the SNP on 
BMI is changing from one Wave to the next (i.e., across time periods). We attempted to age 
match the groups when testing the same ages between 2 different Waves (i.e. time points). 
Given the small sample sizes we combined age groups that overlapped including ages 18–20 
as one group, both in Wave II and Wave III, and ages 25–26 as a second group, both in Wave 
III and Wave IV. Then we ran interaction models by testing the SNP×Wave effect separately 
in each of the two age groupings.
RESULTS
The participants (47% females) were an average of 16.1 years of age (ranging from 13–21 
years) in 1996 (Wave II) and 28.5 years (ranging from 25–34 years) in 2008 (Wave IV). 
Mean BMI in 1996 ranged from 22.9±4.9 kg/m2 in EA to 24.1±5.7 kg/m2 in AA, while in 
2008 mean BMI ranged from 28.5±7.1 kg/m2 in EA to 30.5±8.4 kg/m2 in AA (Table 1). The 
average change per year was largest in AA, 0.54±28 kg/m2 and smallest in EA, 0.45±22 
kg/m2. Analyses using a model without SNPs (Supplementary Table 2) showed significant 
associations with age, sex, and in most cases random effect parameters. Sampling based on 
education in Africans was not significant. Foreign born and ancestry variables in Hispanics 
were not significant except that Cuba had significantly lower change in BMI compared to 
Puerto Ricans (the referent).
In EA, FTO SNP rs9939609 was genome-wide significantly associated (p=2.42e-09) with 
the slope of BMI (e.g. change in BMI over time), suggesting a 0.025 kg/m2 per year of age 
increase in BMI for each additional copy of the established risk allele compared to non-
carriers (Table 2). Similar results were seen for variants (in/near) rs571312 (MC4R), 
rs3817334 (MTCH2), rs6548238 (TMEM18), rs987237 (TFAP2B), and rs543874 
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(SEC16B), with estimated effect sizes suggesting increases in BMI ranging from 0.014 to 
0.025 kg/m2 per year for each additional copy of their respective established risk alleles as 
compared to non-risk allele carriers (Table 2). These results were significant after correcting 
for 34 tests (p<0.0015). Thirty-two of 34 SNPs displayed positive effect estimates on BMI 
change (consistent with the established risk alleles being associated with higher cross-
sectional BMI in prior reports) and 13 of these were at least nominally significant, which is 
more than expected by chance alone (binomial p=3.9E-09). In AA, no SNPs were 
significantly associated with BMI slope. However, 17 of 24 tested had positive beta 
estimates and 5 of these variants in/near SEC16B (rs543874), GNPDA2 (rs10938397), 
ETV5 (rs7647305), LRRN6C (rs10938397), and MAP2K5 (rs2241423) were also nominally 
significant, which is more than expected by chance (binomial p=0.005). In HA, no SNPs 
were significantly associated with BMI slope, but 22 of 34 SNPs had positive beta estimates, 
and four were nominally significant (rs1514175, rs543874, rs9939609, rs12444979, 
respectively in/near TNNI3K, SEC16B, FTO and GPRC5B). In the all ancestry meta-
analysis, 31 of 34 SNPs had positive effect estimates for the established risk allele on change 
in BMI and six SNPs in/near MC4R (rs571312), MTCH2 (rs3817334), TMEM18 
(rs6548238), TFAP2B (rs987237), FTO (rs9939609), and SEC16B (rs543874) displayed 
significant associations after correcting for multiple testing (Figure 1). Again, FTO met 
genome-wide significance. While the statistical significance estimates in the meta-analyses 
for these 6 loci were dominated by the larger EA results, effect estimates were largely 
consistent across ethnic groups. Two notable exceptions were for FTO SNP rs9939609 and 
TFAP2B SNP rs987237, where the effect estimates in AA were noticeably smaller compared 
to EA and HA (Table 2), possibly because these SNPs are not tagging the relevant signal in 
Africans. We calculated the variance explained by each SNP based on our meta-analysis 
results. We calculated the variance explained for a one year change in BMI for each SNP 
based on our European ancestry analysis results (Table 2). The cumulative variance 
explained by the six SNPs that met Bonferroni significance or by the 15 SNPs that met 
nominal significance (p<0.05), is 0.09% 0.37%, respectively.
We next considered whether the loci significantly associated (p<0.05) with change in BMI 
within each ancestry might have different magnitudes of effect at younger compared to older 
ages. Therefore, we tested a SNP-by-age interaction on cross-sectional BMI at each of 
Waves II, III and IV for nine SNPs in EA and two SNPs each in AA and HA. In EA, we 
found two interactions that remained statistically significant after correction for multiple 
testing (p<0.05/9 SNPs=0.0056); a negative estimated SNP-by-age interaction effect on BMI 
at Wave II for rs3817334 (in MTCH2; βinteraction±[se] = −0.192[0.065]) and a positive 
estimated interaction effect for rs987237 (in TFAP2B; βinteraction±[se] = 0.308[0.085]) 
(Table 3 and Supplementary Table 3). Thus, the SNP near TFAP2B had a stronger influence 
on BMI in EA adolescents who were older, while MTCH2 had a stronger influence on BMI 
in EA adolescents who were younger. No other SNP-by-age interactions on BMI at any 
Wave were significant, although SNP-by-age interaction estimates for MTCH2 and TFAP2B 
on BMI were consistent in direction of effect but smaller in magnitude at Waves III and IV 
compared to Wave II.
To aid in interpretation of these effect estimates, we estimated the main effect associations 
between BMI and rs3817334 (in MTCH2) and rs987237 (in TFAP2B), by age group at each 
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Wave (Figure 2). For rs3817334 (in MTCH2), estimated main effects were comparatively 
larger in younger respondents across all Waves, with an increasing range in differences by 
age across time. The magnitude of the estimated effect appears to be driven by the 
individuals who were younger compared to older (e.g. aged ≤ 15 years versus ≥16 years), 
with increased variability in effect estimates in 2001 (Wave II) and again in 2008 (Wave III) 
[Figure 2]. The magnitudes of the estimated main effects were highest across all Waves in 
the youngest participants that were recruited to Add Health and who were age 13–14 years 
at Wave II. For rs987237 (in TFAP2B), the estimated main effects were comparatively larger 
in older respondents across all Waves. We then compared effect sizes in all participants who 
were similar ages but at different points in time (i.e. those who were aged 18–20 years in 
Wave II versus Wave III or 25–26 years in Waves III versus Wave IV). While no SNPs were 
significant for SNP-by-Wave interactions after correcting for multiple testing, both 
rs3817334 in MTCH2 (stronger effects in Wave III than Wave II) and rs987237 in TFAP2B 
(weaker effects in Wave III than Wave II) had nominally significant SNP-by-Wave 
interactions when comparing aged 18–20 year olds between Waves II and III (Table 4 and 
Supplementary Table 4).
DISCUSSION
Over the past decade, numerous common genetic loci have been reported to be associated 
with BMI in primarily European descent adults, as well as in other ancestral groups, and at 
one or more phases of the life course including adulthood [4, 21, 29, 39–41], childhood [7, 
42–44] and adolescence [7, 26, 45]. We extended these findings to interrogate 34 known 
obesity-related loci for association with change in BMI across the transition from 
adolescence to adulthood in an ethnically diverse, nationally representative cohort of 
adolescents followed over 13 years into adulthood.
Among EA, we observed statistically significant positive associations with change in BMI 
(when oriented on the obesity susceptibility allele) from adolescence into adulthood for 6 of 
34 known obesity loci tested, including one FTO variant (rs9939609) that met genome-wide 
significance. Results were similar in the meta-analyses including EA, HA and AA. Among 
six Bonferroni-corrected significant SNPs, only FTO, MC4R, TFAP2B, and SEC16B have 
been shown to be associated with cross-sectional measures of BMI during adolescence in 
this cohort [26]. The variance explained for a one year change in BMI the by six Bonferroni-
corrected significant SNPs or the 15 SNPs that met nominal significance is clinically rather 
small. How this extends beyond one year is not something we can extrapolate here. 
However, we have only tested a selection of SNPs and there are likely others that influence 
change in BMI in addition to those tested here. Our work confirms previous findings in 
younger children (ages one to 16 years) of European descent of positive associations 
between BMI-related loci and BMI trajectories of at least nominal significance with FTO, 
MC4R, SEC16B, TMEM18, TFAP2B and MTCH2 [13]. Other analysis of FTO variant 
rs9939609 and MC4R variant rs17782313 (R2=0.96 with the MC4R SNP rs571312 we 
tested) associations with change in BMI from childhood into adulthood in a sample of 2,479 
European descent individuals suggested comparatively stronger association with BMI from 
age two to 20 years and then weakening to age 53 [7]. In our study, FTO variant rs9939609 
and MCR4 variant rs571312 were positively associated with change in BMI, however, 
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though consistent in direction with the prior report, the effects of these variants in higher vs. 
lower ages in Wave-stratified age-by-SNP interaction analyses were not significant. A 
longitudinal study in over 41,000 European descent adults from three studies, mean ages 60, 
45, and 58 years, found no statistically significant association with FTO and change in BMI 
across a 10-year period of time [46]. Thus, FTO may play a comparatively less prominent 
role in relation to weight change in later adulthood. A recent study comparing genome-wide 
genetic effects on BMI in younger adults <=50 years versus older adults (>50 years) showed 
11 of 15 loci with greater estimated effects on younger adults [43]. None of the 11 loci were 
associated with birth weight, yet all but one were nominally associated with increased risk of 
childhood obesity and BMI in 16-to-25 year-olds, suggesting that some loci exert genetic 
effects relatively early in life and into young adulthood. Among the 11 loci were variants in 
FTO, MC4R, SEC16B, and TMEM18 that are in high linkage disequilibrium (R2>0.8) with 
those identified in the current study.
Change in BMI over time, and the effects of genotype on this change, is likely impacted by 
many factors including changes in age and environment. Many of the specific environmental 
factors are either unknown or difficult to adequately measure and/or represent in a social 
epidemiological study. Over the past couple of decades, there has been a profound increase 
in obesity in both adolescent and adult populations due to a number of external factors 
strongly associated with the time period. In our study, like most social and epidemiological 
longitudinal studies, the impact of change in age and general change in environment 
captured by year of study (Wave) are highly confounded. In addition to assessing 
longitudinal change in BMI, we also performed Wave-stratified age-by-SNP interactions and 
age-matched Wave-by-SNP interactions between adjacent Waves to attempt to tease apart 
this confounding. Our findings suggest that the etiology for the observed strengthening 
associations between established BMI variants and BMI during the period of adolescence 
and young-adulthood is complex and may be a function of both the aging process and 
exposure to an increasingly obesogenic environment[47]. The interaction between rs987237 
(near TFAP2B) and age suggests that this variant has stronger effects on BMI in older 
adolescents/young adults (in the 13–21 year age range at Wave II, the estimated increase in 
BMI from each established risk allele is 2.5kg/m2 greater for those at age 21 compared to 
those at age 13). On the other hand, for MTCH2 variant rs3817334, we observed evidence 
for stronger estimated effects on BMI at younger ages as suggested by the significant 
interaction of age and rs3817334 during Wave II when participants ranged from 13 to 21 
years old. Given the main and interaction effect sizes, the estimated increase in BMI per T 
allele of rs3817334 is 1.5kg/m2 greater in those who are 13 years at Wave II versus those 
who are 21 years at Wave II. Interestingly, we also found supporting evidence for this same 
variant having stronger effects on BMI in later Waves (e.g. stronger in Wave II vs. Wave III) 
in age-matched participants. For TFAP2B variant rs987237, the effects appear to be stronger 
in earlier Waves among age-matched participants. MTCH2 is highly expressed in white 
adipose tissue and adipocytes, and thought to play a regulatory role in adipocyte 
differentiation and biology, while TFAP2B mRNA expression has been shown to be 
correlated negatively with leptin and positively with IL-6 expression in both subcutaneous 
and omental adipose tissues [48]. Possibly MTCH2 might influence younger individuals 
more in playing a role during puberty while TFAP2B might have a stronger effect in older 
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individuals in that cytokines (e.g. IL-6) have markedly lower levels in children versus adults 
[49]. For the other variants associated with change in BMI, we found no significant evidence 
pointing to differential effects across ages or year of study.
While our study capitalizes on an ancestrally diverse, nationally representative cohort 
measured during a unique period of the lifecycle, there are limitations. There is a lack of 
established obesity loci in HA and power in HA for common loci in our study was limited 
by smaller sample sizes. In addition, the age range of our participants limited our ability to 
separate differences in effect by age that might be due to cohort, time, and or age. The Add 
Health sample is largely comprised of post-pubertal adolescents. For example <1% of Add 
Health females had not achieved menarche by wave I. Nonetheless we conducted a 
sensitivity analysis with (and without) adjustment for age at menarche in women (we have 
no such comparable measure for men) (Supplementary Table 5). This sensitivity analysis 
suggests little difference and therefore would infer that there is little confounding from lack 
of adjustment for puberty. We were unable to test periods of the life course that might be 
defined as childhood or middle- to late-adulthood, making comparisons with other studies 
difficult. However, these questions extend beyond the scope of the current study given our 
sample. Finally, while it is possible, most common variants are not affected by pop 
stratification in Europeans which is where we find most results. We are not well powered to 
detect effects in these samples. Thus, it is not likely that we are reporting any false positives.
In conclusion, we demonstrated that several established BMI variants are positively 
associated with change in BMI during the period of adolescence and young-adulthood. 
Through stratified analyses, we demonstrate that MTCH2 variant rs3817334 has stronger 
effects on BMI in younger participants and in later Wave (i.e. time periods), and that 
TFAP2B variant rs987237 has stronger effects in older participants and in earlier Waves. 
Due to the confounding between age and Wave in longitudinal analyses, stratified analyses 
were necessary to tease apart these directionally conflicted findings for both variants. Our 
results suggest that the genetic effect of BMI loci varies over time in a complex manner, 
highlighting the importance of investigating loci influencing obesity risk across the life 
course.
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Figure 1. 
For SNPs that achieved statistical significance at p<0.05 across the meta-anlayzed sample, 
effect estimates for per allele change in slope of BMI across adolescence to young adulthood 
for the Add Health cohort by ethnic/race group and combined.
*Denotes SNPs that do not generalize to African Americans and thus were not considered.
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Figure 2. 
Effect estimates of (a) rs3817334 (near MTCH2) and (b) rs987237 (near TFAP2B) with 
cross-sectional measures of BMI at each Wave by age group at Wave II.a
a
 To aid in interpretation, we plotted the results by year of age at each Wave, except for those 
aged 13–14 and aged 18–21 which we combined due to smaller sample sizes.
Sample sizes for MTCH2:
Aged 13–14 in 1996 (N=961 in Wave II, N=836 in Wave III, N=975 in Wave IV)
Aged 15 in 1996 (N=961 in Wave II, N=836 in Wave III, N=975 in Wave IV)
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Aged 16 in 1996 (N=1007 in Wave II, N=840 in Wave III, N=1023 in Wave IV)
Aged 17 in 1996 (N=960 in Wave II, N=782 in Wave III, N=974 in Wave IV)
Aged 18–21 in 1996 (N=1022 in Wave II, N=904 in Wave III, N=1069 in Wave IV)
Sample sizes for TFAP2B:
Aged 13–14 in 1996 (N=966 in Wave II, N=843 in Wave III, N=980 in Wave IV)
Aged 15 in 1996 (N=835 in Wave II, N=715 in Wave III, N=845 in Wave IV)
Aged 16 in 1996 (N=1009 in Wave II, N=842 in Wave III, N=1025 in Wave IV)
Aged 17 in 1996 (N=967 in Wave II, N=789 in Wave III, N=981 in Wave IV)
Aged 18–21 in 1996 (N=1028 in Wave II, N=908 in Wave III, N=1075 in Wave IV)
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